Plain-English translation of NCT06289374 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
The LABS Study is investigating biological markers (biomarkers) in people who have been treated for adenocarcinoma of the gullet or stomach. By collecting samples like saliva, blood, urine, and breath at set intervals after surgery, researchers hope to discover which markers can predict how well someone will respond to treatment, whether the cancer might return, and what their long-term prognosis might be.
Gullet and stomach cancers have poor survival rates, with only about 15% of patients surviving beyond 5 years. Researchers believe that understanding the relationship between the cancer-related microbiome (bacteria and microorganisms), inflammation, and cancer progression could help predict outcomes and improve care for future patients.
You likely qualify if…
You likely don't qualify if…
If you join, you will visit the research team at 3 months, 6 months, 1 year, and 2 years after your cancer surgery. At each visit, you will provide small samples of saliva, blood, urine, and breath, and you'll complete a brief questionnaire about your quality of life. The entire study spans two years from your surgery, and each visit takes about one to two hours.
AI-generated summary from trial data · Jun 19, 2026 · Not medical advice
United Kingdom